InSure® ONE™: Preventing colorectal cancer through early detection
Screening can save lives
Colorectal cancer is the second leading cause of cancer deaths in the United States and, according to the American Cancer Society, more than 50,000 people will die from it in the U.S. in 2017. As with almost all cancers, early detection combined with healthy lifestyle choices are critical to reducing incidence. Health and wellness programs that incorporate colorectal screenings, such as InSure® ONE™, are an essential part of this process.
If detected early in stage I or II, colorectal cancer is often treatable and the five-year survival rate soars to higher than 90 percent. However, once the disease spreads, the survival rate plummets to less than 10 percent.
Download the InSure® ONE™ Product Overview to learn more.
Insights from Quest Diagnostics
Sign up to receive the latest news and insights about health and well-being.
Thanks for signing up!
You’re all set to begin receiving white papers from Quest Diagnostics.